Covered recipient · General Payments record
TRUSHAR PATEL
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$74,532.33
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,370.00 | 7 |
| Food and Beverage | $2,127.14 | 24 |
| Travel and Lodging | $956.68 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BAXTER HEALTHCARE | $6,440.71 | 7 |
| HISTOSONICS, INC. | $988.43 | 4 |
| COLOPLAST CORP | $805.48 | 9 |
| Ethicon Inc. | $450.00 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $402.99 | 3 |
| UROGEN PHARMA, INC. | $136.79 | 2 |
| Janssen Biotech, Inc. | $133.22 | 1 |
| Ambu Inc. | $46.17 | 1 |
| AngioDynamics, Inc. | $25.81 | 1 |
| PROCEPT BioRobotics Corporation | $24.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ambu Inc. | $46.17 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134082052 | CMS |
| AngioDynamics, Inc. | $25.81 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095090898 | CMS |
| Baxter Healthcare | $138.62 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120588999 | CMS |
| Baxter Healthcare | $43.93 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120589002 | CMS |
| Baxter Healthcare | $144.79 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120588995 | CMS |
| Baxter Healthcare | $55.40 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120589010 | CMS |
| Baxter Healthcare | $2,960.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1114408223 | CMS |
| Baxter Healthcare | $2,960.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1114408225 | CMS |
| Baxter Healthcare | $137.97 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120589007 | CMS |
| Boston Scientific Corporation | $128.91 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092435451 | CMS |
| Boston Scientific Corporation | $129.85 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092435453 | CMS |
| Boston Scientific Corporation | $144.23 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092435455 | CMS |
| COLOPLAST CORP | $6.92 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117440880 | CMS |
| COLOPLAST CORP | $173.91 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117440972 | CMS |
| COLOPLAST CORP | $67.12 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117440974 | CMS |
| COLOPLAST CORP | $135.70 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117440978 | CMS |
| COLOPLAST CORP | $180.40 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117440976 | CMS |
| COLOPLAST CORP | $16.31 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117441016 | CMS |
| COLOPLAST CORP | $23.48 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117441040 | CMS |
| COLOPLAST CORP | $174.10 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117441042 | CMS |
| COLOPLAST CORP | $27.54 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117441048 | CMS |
| Ethicon Inc. | $150.00 | 07/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077585960 | CMS |
| Ethicon Inc. | $50.00 | 08/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077585962 | CMS |
| Ethicon Inc. | $150.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077585966 | CMS |
| Ethicon Inc. | $50.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077585964 | CMS |
| Ethicon Inc. | $50.00 | 12/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077585958 | CMS |
| HISTOSONICS,INC. | $736.20 | 05/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154802321 | CMS |
| HISTOSONICS,INC. | $32.00 | 05/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154802323 | CMS |
| HISTOSONICS,INC. | $31.75 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154802325 | CMS |
| HISTOSONICS,INC. | $188.48 | 06/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154802319 | CMS |
| Janssen Biotech, Inc. | $133.22 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078496414 | CMS |
| PROCEPT BioRobotics Corporation | $24.22 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144027171 | CMS |
| UROGEN PHARMA, INC. | $116.67 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137927234 | CMS |
| UROGEN PHARMA, INC. | $20.12 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137925736 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.